1 year ago

India's Pharma Innovation Faces Funding Hurdles, Says DCGI

India's Pharma Innovation Faces Funding Hurdles, Says DCGI
One takeaway of FE Healthcare Summit & Awards 2025: Risk capital to fund innovation in pharma limited in India · financialexpress.com

At a healthcare summit, India's drug controller said that there isn't enough money to fund new medicine ideas in India.

He wants companies to find international investors to help.

The government is also making it easier to follow the rules.

India, known for making generic medicines, needs to start focusing on creating new and valuable medicines, not just copies of existing ones.

Companies like Dr. Reddy's are trying to sell more than just generic medicines.

They are starting new partnerships and buying other businesses to expand their products, like vitamins and medicines to help people quit smoking.

Doctors also emphasized the increasing health issues such as cancer and diabetes.

Key facts

Event
FE Healthcare Summit & Awards 2025
Speaker (DCGI)
Rajeev Singh Raghuvanshi
Pharma Focus
Generics and Innovation
Company Example
Dr. Reddy’s Laboratories
Dr. Reddy's Venture
Nestlé India
Health Issue
Non-communicable diseases

Sources

Related news